Arete Wealth Advisors, LLC Mustang Bio, Inc. Transaction History

Arete Wealth Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.46 - $7.2 $7,147 - $111,873	15,538 New	15,538 $7,000
Q2 2022 Aug 15, 2022	SELL	$0.58 - $1.13 $9,012 - $17,557	-15,538 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$1.66 - $2.64 $25,793 - $41,020	15,538 New	15,538 $26,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Arete Wealth Advisors, LLC with notifications on news.